These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2585944)

  • 1. Serum amphotericin B concentration in a very premature infant with disseminated candidiasis.
    Nirasawa M; Sugaya N; Mitamura K; Komiyama T; Kikuchi H; Oikawa T
    Keio J Med; 1989 Sep; 38(3):319-24. PubMed ID: 2585944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Candida arthritis with flucytosine and amphotericin B.
    Weisse ME; Person DA; Berkenbaugh JT
    J Perinatol; 1993; 13(5):402-4. PubMed ID: 8263628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.
    Baley JE; Meyers C; Kliegman RM; Jacobs MR; Blumer JL
    J Pediatr; 1990 May; 116(5):791-7. PubMed ID: 2329429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans meningitis in a premature neonate successfully treated with 5-fluorocytosine and amphotericin B: a case report and review of the literature.
    Lilien LD; Ramamurthy RS; Pildes RS
    Pediatrics; 1978 Jan; 61(1):57-61. PubMed ID: 263875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic treatment of systemic candidiasis in newborns.
    Serra G; Mezzano P; Bonacci W
    J Chemother; 1991 Jan; 3 Suppl 1():240-4. PubMed ID: 12041777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Denning DW; Drusano GL
    J Infect Dis; 2005 Aug; 192(4):673-80. PubMed ID: 16028137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
    Kamitsuka MD; Nugent NA; Conrad PD; Swanson TN
    Pediatr Infect Dis J; 1995 Apr; 14(4):329-31. PubMed ID: 7603822
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphotericin B dosage for disseminated candidiasis in premature infants.
    Hall JE; Cox F; Karlson K; Robertson A
    J Perinatol; 1987; 7(3):194-8. PubMed ID: 3332892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
    Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
    An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased level/dose ratio of amphotericin-B in premature infants with renal failure.
    Higuchi R; Kusumoto S; Ban H; Iwahashi S; Kobayashi M; Sumiyama K; Koike M
    Acta Paediatr Jpn; 1993 Jun; 35(3):238-42. PubMed ID: 8351992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from disseminated candidiasis in a premature neonate.
    Hill HR; Mitchell TG; Matsen JM; Quie PG
    Pediatrics; 1974 May; 53(5):748-52. PubMed ID: 4545261
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal amphotericin B in neonates with invasive candidiasis.
    Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
    Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis.
    Smego RA; Perfect JR; Durack DT
    Rev Infect Dis; 1984; 6(6):791-801. PubMed ID: 6522917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).
    Johnson DE; Thompson TR; Green TP; Ferrieri P
    Pediatrics; 1984 Feb; 73(2):138-43. PubMed ID: 6694869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis.
    Ward RM; Sattler FR; Dalton AS
    Pediatrics; 1983 Aug; 72(2):234-8. PubMed ID: 6866610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis.
    Biyikli NK; Tugtepe H; Akpinar I; Alpay H; Ozek E
    Pediatr Nephrol; 2004 Jul; 19(7):801-4. PubMed ID: 15173938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.
    Arrieta AC; Shea K; Dhar V; Cleary JP; Kukreja S; Morris M; Vargas-Shiraishi OM; Ashouri N; Singh J
    Clin Ther; 2010 Feb; 32(2):265-71. PubMed ID: 20206784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B in neonates with invasive candidiasis.
    al Arishi H; Frayha HH; Kalloghlian A; al Alaiyan S
    Am J Perinatol; 1997 Oct; 14(9):573-6. PubMed ID: 9394170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
    Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.